Know Cancer

or
forgot password

A Randomized Controlled Trial of the Effectiveness of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer


N/A
N/A
N/A
Not Enrolling
Both
Thyroid Cancer

Thank you

Trial Information

A Randomized Controlled Trial of the Effectiveness of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer


Inclusion Criteria:



- >18 years old

- They had a histological diagnosis of papillary, follicular, medullary or anaplastic
thyroid cancer

- They had undergone total thyroidectomy

- They were able to provide consent

Exclusion Criteria:

- patients who had distant metastases,

- a history of salivary-gland disorders,

- collagen tissue disease

- diabetes mellitus,

- previous radioiodine therapy or external radiation to the head or neck

- allergy to the honey

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention

Outcome Measure:

Grade of sialadenitis

Outcome Time Frame:

Change from Baseline grade of sialadenitis at 6 and 24 months

Safety Issue:

No

Principal Investigator

Andreas Charalambous, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Cyprus University of Technology

Authority:

Cyprus: Bank of Cyprus Oncology Center Research Committee

Study ID:

AC-HCS-89

NCT ID:

NCT01833650

Start Date:

May 2013

Completion Date:

September 2014

Related Keywords:

  • Thyroid Cancer
  • thyroid cancer
  • radioiodine treatment
  • xerostomia
  • sialadenitis
  • Thyroid Neoplasms
  • Thyroid Diseases

Name

Location